← Back to Screener
Bone Biologics Corp Common Stock (BBLG)
Price$1.38
Favorite Metrics
Price vs S&P 500 (26W)-51.55%
Price vs S&P 500 (4W)10.33%
Market Capitalization$2.50M
All Metrics
Book Value / Share (Quarterly)$3.00
P/TBV (Annual)0.35x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-1.50
Price vs S&P 500 (YTD)-8.28%
EPS (TTM)$-4.00
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-4.00
EPS (Annual)$-2.65
ROI (Annual)-57.81%
Cash / Share (Quarterly)$2.97
ROA (Last FY)-53.64%
EBITD / Share (TTM)$-2.76
ROE (5Y Avg)-106.62%
Cash Flow / Share (Annual)$-1.50
P/B Ratio0.46x
P/B Ratio (Quarterly)0.48x
Net Income / Employee (Annual)$-2
Net Interest Coverage (TTM)-0.99x
ROA (TTM)-55.74%
EPS Incl Extra (Annual)$-2.65
Current Ratio (Annual)13.85x
Quick Ratio (Quarterly)13.27x
3-Month Avg Trading Volume0.21M
52-Week Price Return-65.42%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.21
52-Week High$6.75
EPS Excl Extra (Annual)$-2.65
26-Week Price Return-42.80%
Quick Ratio (Annual)13.27x
13-Week Price Return-13.66%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)13.85x
Enterprise Value$-2.839
Revenue / Employee (Annual)$0
Cash / Share (Annual)$2.97
3-Month Return Std Dev55.43%
Net Income / Employee (TTM)$-2
ROE (Last FY)-57.81%
Net Interest Coverage (Annual)-1.01x
EPS Basic Excl Extra (Annual)$-2.65
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-4.00
ROI (TTM)-59.50%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$11.66
Price vs S&P 500 (52W)-100.52%
Year-to-Date Return-4.14%
5-Day Price Return13.01%
EPS Normalized (Annual)$-2.65
ROA (5Y Avg)-88.21%
Month-to-Date Return26.36%
EBITD / Share (Annual)$-2.75
ROI (5Y Avg)-106.62%
EPS Basic Excl Extra (TTM)$-4.00
P/TBV (Quarterly)0.54x
P/B Ratio (Annual)0.48x
Book Value / Share (Annual)$3.00
Price vs S&P 500 (13W)-16.53%
Beta0.74x
Revenue / Share (TTM)$0.00
ROE (TTM)-59.50%
52-Week Low$1.05
Analyst Recommendations
Aug 2023
Sep 2023
Oct 2023
Nov 2023
4.14
4.14
4.14
4.14
Industry Peers — Orthopedic & Prosthetic Devices(26)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BBLGBone Biologics Corp Common Stock | — | — | — | — | $1.38 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
About
Bone Biologics is a biotechnology company developing bone regeneration therapeutics. Its lead product, NELL-1, is a bone void filler designed for spinal, orthopedic, neurosurgery, and sports medicine procedures, with additional applications in plastic reconstruction and interventional radiology.